期刊文献+

单克隆抗体在疾病治疗中的应用

The use of monoclonal antibodies in disease therapy
原文传递
导出
摘要 单克隆抗体(单抗)技术与分子生物学技术的结合使重组嵌合抗体、人源化抗体和全人抗体的技术得到迅速发展。由于这些单抗带有人抗体的Fc片段,因此,这些抗体不仅能中和抗原,更重要的是能介导细胞毒作用和激活补体系统。这些抗体已被用于治疗某些疾病,如癌症、免疫性疾病、感染性疾病和器官移植排斥。随着大规模CHO细胞生产工艺的发展,越来越多的单抗将应用于临床。 Combination of the technologies of the monoclonal antibody and molecular biology leads to rapid development of the techniques of chimeric antibody, humanized antibody and full human antibody. Because of having Fc region from human IgG, these antibodies can not only neutralize antigen, but also, most importantly, mediate ADCC and activate complement system. Monoclonal antibodies have been used in the treatment of some diseases, such as cancer, immune disease, infectious disease and organ transplant rejection. With the development of CHO cell culture process on a larger scale, more and more monoclonal antibodies will be in the clinical application.
出处 《国际生物制品学杂志》 CAS 2009年第5期265-268,共4页 International Journal of Biologicals
关键词 抗体 单克隆 药理作用 治疗应用 疾病 Antibodies, monoclonal Pharmacologic actions Therapeutic uses Disease
  • 相关文献

参考文献24

  • 1Casadevall A, Scharff MD. Serum therapy revisited: animal models of infection and development of passive antibody therapy [ J ]. Antimicrob Agents Chemother, 1994, 38 (8) : 1695-1702.
  • 2Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity [ J]. Nature, 1975, 256 (5517) :495-497.
  • 3Carter PJ. Potent antibody therapeutics by design [ J ]. Nat rev Immunol, 2006, 6 (5) :343-357.
  • 4Aggarwal S. What's fueling the biotech engine-2007[ J ]. Nat Biotechnol, 2008, 26( 11 ) : 1227-1233.
  • 5Maraseo WA, Sui J. The growth and potential of human antiviral monoclonal antibody therapeutics [ J]. Nat Biotechnol, 2007,25 ( 12 ) : 1421-1434.
  • 6Robinson RF, Nabata MC. Respiratory syncytial virus ( RSV ) immune globulin and palivizumab for prevention of RSV infection [J]. Am J Health Syst Pharm, 2000, 57(3) :259-264.
  • 7Du Pan SM, Gabay C, Finckh A. A systematic review of infliximab in the treatment of early rheumatoid arthritis [ J]. Ther Clin Risk Manag. 2007, 3(5) :905-911.
  • 8Cragg MS, French RR, Glennie MJ. Signaling antibodies in cancer therapy [ J]. Curr Opin Immunol, 1999, 11 (5) : 541-547.
  • 9Liu XY, Pop LM, Vitetta ES. Engineering therapeutic monocloual antibodies [J]. Immunol Rev, 2008, 222:9-27.
  • 10Pescovitz MD. Rituximab, an anti-CD20 monoelonal antibody: history and mechanism of action [ J ]. Am J Transplant, 2006, 6 (5 Pt1) :859-866.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部